Shares of Evolent Health Inc. (NYSE:EVH) fell 3.9% during mid-day trading on Thursday . The stock traded as low as $23.30 and last traded at $23.35, with a volume of 199,135 shares trading hands. The stock had previously closed at $24.29.

Several brokerages recently issued reports on EVH. FBR & Co reaffirmed a “buy” rating on shares of Evolent Health in a research note on Saturday, May 14th. Zacks Investment Research cut shares of Evolent Health from a “hold” rating to a “sell” rating in a research note on Wednesday, May 4th. Canaccord Genuity reissued a “buy” rating and issued a $30.00 price target on shares of Evolent Health in a research note on Sunday, August 7th. Jefferies Group began coverage on shares of Evolent Health in a research note on Tuesday, July 26th. They issued a “buy” rating and a $28.00 price target for the company. Finally, Leerink Swann reissued an “outperform” rating and issued a $20.00 price target on shares of Evolent Health in a research note on Sunday, July 17th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Evolent Health presently has a consensus rating of “Buy” and an average target price of $22.50.

The company’s market cap is $1.48 billion. The company has a 50-day moving average of $23.17 and a 200 day moving average of $15.00.

Evolent Health (NYSE:EVH) last announced its quarterly earnings data on Thursday, August 4th. The company reported ($0.12) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.16) by $0.04. The company earned $56.50 million during the quarter, compared to analyst estimates of $51.96 million. The firm’s revenue for the quarter was up 443.3% on a year-over-year basis. During the same quarter last year, the business earned ($0.95) EPS. Equities research analysts anticipate that Evolent Health Inc. will post ($0.55) earnings per share for the current year.

A hedge fund recently raised its stake in Evolent Health stock. Wells Fargo & Company MN increased its stake in shares of Evolent Health Inc. (NYSE:EVH) by 22.0% during the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 808,909 shares of the company’s stock after buying an additional 145,685 shares during the period. Wells Fargo & Company MN owned 1.37% of Evolent Health worth $9,796,000 at the end of the most recent reporting period.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.